GLG News Analyses of the following article:
New 'Targeted' Treatments Improve Colon Cancer Survival Rates
Published at: www.medicalnewstoday.com
-
"targeted Therapies" can have Serious side effects
April 9, 2007
Targeted therapies have incraesed response rates in several advanced cancers such as colorectal, renal, pancreatic , and non-small lung cancer.
None of the natural compounds have been approved as a medication yet in the US.
Many of the "targeted " agents such as Avastin, Nexavar, and Tarceva, have serious side effects such as hypertension, increased bleeding, rash, fatigue, diarrhea , and increased infection rates.
- Subscribe to Updates
-
Work for one of the world's leading organizations? Get started now.
Get Intelligently Connected
with the world's leading experts
GLG's 850+ Clients Include:
- More than 70% of the world's leading
- mutual funds
- 15 of the leading 20
- global banks
- 9 of the leading 10
- global private equity firms
- 5 of the leading 10
- AmLaw firms
- Fortune 500® Companies
- in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.